BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 38 found
  Current Search:  poly: 38, rx: 452     

HTML
58%
Why Do Cancer Patients Suffer Twice ? 1. The Disease Itself & 2. The Treatment Of The Disease
A study was conducted by Dr.

Forsythe on 225 patients for three years with varying Stage IV cancers.

All patients utilized Poly-MVA and showed up to a 60% positive response rate with many continuing to survive years after the study.

FOR IMMEDIATE...

PRLog:  Feb 9 2010 4:56AM
Matching: poly
Find similar documents
HTML
58%
New Animal Model for Evaluating Antiviral Agents Against the SARS Virus Indicates Potential Effect of Ampligen
PHILADELPHIA, Feb.

8, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc.

(NYSE Amex:HEB) (the 'Company') reported a recent study, published in the December 20th issue of Virology (2009) by a consortium of researchers at Utah State University and the...

Therapeutics Daily:  Feb 8 2010 3:19PM
Matching: poly
Find similar documents
HTML
58%
Poly Medicure plans Rs 40 cr expansion in medical devices segment
_ Poly Medicure plans Rs 40 cr expansion in medical devices segment.
PharmaBiz:  Feb 8 2010 6:52AM
Matching: poly
Find similar documents
HTML
58%
Cosmetic Use of Poly-l-Lactic Acid: A Retrospective Study of 130 Patients
_ Cosmetic Use of Poly-l-Lactic Acid: A Retrospective Study of 130 Patients.
MDLinx:  Feb 5 2010 11:52AM
Matching: poly
Find similar documents
HTML
58%
Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Ampligen(R) Manufacturing Response
(GlobeNewswire via COMTEX) ----Hemispherx Biopharma, Inc.

(NYSE Amex:HEB) (the "Company"), announced that the Company, via its manufacturing subcontractor, received a favorable response from the Food and Drug Administration ("FDA") Seattle District Office (...

FOXBusiness.com:  Feb 2 2010 5:29PM
Matching: poly
Find similar documents
HTML
58%
Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Ampligen(R) Manufacturing Response
(GlobeNewswire via COMTEX) ----Hemispherx Biopharma, Inc.

(NYSE Amex:HEB) (the "Company"), announced that the Company, via its manufacturing subcontractor, received a favorable response from the Food and Drug Administration ("FDA") Seattle District Office (...

FOXBusiness.com:  Feb 2 2010 5:29PM
Matching: poly
Find similar documents
HTML
58%
Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Amp
PHILADELPHIA, Feb.

2, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc.

(NYSE Amex:HEB) (the Company), announced that the Company, via its manufacturing subcontractor, received a favorable response from the Food and Drug Administration (FDA) Seattle...

Yahoo! Canada:  Feb 2 2010 5:25PM
Matching: poly
Find similar documents
HTML
58%
Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Ampligen(R) Manufacturing Response
PHILADELPHIA, Feb.

2, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc.

(NYSE Amex:HEB) (the ?Company?), announced that the Company, via its manufacturing subcontractor, received a favorable response from the Food and Drug Administration (?FDA?) Seattle...

DMN Newswire:  Feb 2 2010 4:29PM
Matching: poly
Find similar documents
HTML
58%
Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Ampligen(R) Manufacturing Response
PHILADELPHIA, Feb.

2, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc.

(NYSE Amex:HEB) (the ?Company?), announced that the Company, via its manufacturing subcontractor, received a favorable response from the Food and Drug Administration (?FDA?) Seattle...

DMN Newswire:  Feb 2 2010 4:26PM
Matching: poly
Find similar documents
HTML
58%
Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Ampligen(R) Manufacturing Response
Hemispherx Biopharma, Inc.

(NYSE Amex:HEB) (the "Company"), announced that the Company, via its manufacturing subcontractor, received a favorable response from the Food and Drug Administration ("FDA") Seattle District Office ("DO") related to the latest...

Individual.com:  Feb 2 2010 3:34PM
Matching: poly
Find similar documents
HTML
58%
Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Ampligen(R) Manufacturing Response
PHILADELPHIA, Feb.

2, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc.

(NYSE Amex: HEB) (the "Company"), announced that the Company, via its manufacturing subcontractor, received a favorable response from the Food and Drug Administration ("FDA") Seattle...

Street Insider:  Feb 2 2010 3:24PM
Matching: poly
Find similar documents
HTML
58%
Hemispherx Biopharma Receives Favorable Notice Via Its
PHILADELPHIA, Feb.

2, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc.

(NYSE Amex:HEB) (the 'Company'), announced that the Company, via its manufacturing subcontractor, received a favorable response from the Food and Drug Administration ('FDA') Seattle...

GlobeNewswire via MSN Money:  Feb 2 2010 3:19PM
Matching: poly
Find similar documents
HTML
58%
Gene Therapy: New gene therapy findings from University Hospital described
Today's Medical & Research News Gene Therapy New gene therapy findings from University Hospital described February 1st, 2010 Printer-Friendly Version City:Granada Country:Spain Adenosine Angiogenesis Biotechnology Drugs Enzymes Gene Therapy Genetics...
NewsRX:  Feb 1 2010 5:28AM
Matching: poly
Find similar documents
HTML
58%
Inhibition of Poly(ADP)-Ribose Polymerase as a Therapeutic Strategy for Breast Cancer
Department of Medicine Clinical Genetics and Breast Cancer Medicine Services Memorial Sloan-Kettering Cancer Center New York, New York | January 26, 2010 ABSTRACT: As knowledge increases about the processes underlying cancer, it is becoming feasible to design...
Cancernetwork.com:  Jan 27 2010 9:23AM
Matching: poly
Find similar documents
HTML
58%
4 medical officers for Anaesthesia Department of Poly Clinic approved
The Health Ministry has approved the appointment of four experienced medical officers in Anaesthesia Department of Federal Government Services Hospital.

4 medical officers for Anaesthesia Department of Poly Clinic approved.

Individual.com:  Jan 27 2010 5:17AM
Matching: poly
Find similar documents
HTML
58%
Biotech Stock Alert for Hemispherx Biopharma Inc. Issued by InvestorSoup
DALLAS, Jan.

25, 2010 (GLOBE NEWSWIRE) -- InvestorSoup.com announces an investment report featuring Hemispherx Biopharma Inc.

(AMEX:HEB - News).

The report includes financial, comparative and investment analyses, and pertinent industry information you...

Yahoo! Canada:  Jan 25 2010 1:31PM
Matching: poly
Find similar documents
HTML
58%
Biotech Stock Alert for Hemispherx Biopharma Inc. Issued by InvestorSoup
(GlobeNewswire via COMTEX) ----InvestorSoup.com announces an investment report featuring Hemispherx Biopharma Inc.

(AMEX:HEB).

The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an...

FOXBusiness.com:  Jan 25 2010 12:56PM
Matching: poly
Find similar documents
HTML
58%
Biotech Stock Alert for Hemispherx Biopharma Inc. Issued by InvestorSoup
(GlobeNewswire via COMTEX) ----InvestorSoup.com announces an investment report featuring Hemispherx Biopharma Inc.

(AMEX:HEB).

The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an...

FOXBusiness.com:  Jan 25 2010 12:54PM
Matching: poly
Find similar documents
HTML
58%
Biotech Stock Alert for Hemispherx Biopharma Inc. Issued by InvestorSoup
DALLAS, Jan.

25, 2010 (GLOBE NEWSWIRE) -- InvestorSoup.com announces an investment report featuring Hemispherx Biopharma Inc.

(AMEX:HEB).

The report includes financial, comparative and investment analyses, and pertinent industry information you need to...

DMN Newswire:  Jan 25 2010 12:54PM
Matching: poly
Find similar documents
HTML
58%
Biotech Stock Alert for Hemispherx Biopharma Inc. Issued by Inves...
Company: Hemispherx BioPharma, Inc.

(HEB) InvestorSoup.com announces an investment report featuring Hemispherx Biopharma Inc.

(AMEX:HEB).

The report includes financial, comparative and investment analyses, and pertinent industry information you need to...

Zibb:  Jan 25 2010 12:42PM
Matching: poly
Find similar documents
HTML
58%
Biotech Stock Alert for Hemispherx Biopharma Inc. Issued by
DALLAS, Jan.

25, 2010 (GLOBE NEWSWIRE) -- InvestorSoup.com announces an investment report featuring Hemispherx Biopharma Inc.

(AMEX:HEB).

The report includes financial, comparative and investment analyses, and pertinent industry information you need to...

GlobeNewswire via MSN Money:  Jan 25 2010 12:23PM
Matching: poly
Find similar documents
HTML
58%
Biotech Stock Alert for Hemispherx Biopharma Inc. Issued by InvestorSoup
DALLAS, Jan.

25, 2010 (GLOBE NEWSWIRE) -- InvestorSoup.com announces an investment report featuring Hemispherx Biopharma Inc.

(AMEX: HEB).

The report includes financial, comparative and investment analyses, and pertinent industry information you need to...

Street Insider:  Jan 25 2010 11:58AM
Matching: poly
Find similar documents
HTML
58%
Microassay for Glucose-Induced Preproinsulin mRNA Expression to Assess Islet Functional Potency for Islet Transplantation
Background.

The capacity for insulin synthesis in islets is important for islet transplantation to succeed.

We developed a microassay that evaluates the potency of human islets by measuring changes in glucose-induced human insulin gene (INS) expression...

Transplantation:  Jan 23 2010 12:21AM
Matching: poly
Find similar documents
HTML
58%
Poly-Pacific Announces Appointment of Philip Kempisty to Board of Directors and Proposed Share Consolidation
Poly-Pacific International Inc.

('Poly-Pacific' or the 'Company') (TSX VENTURE: PMB)(OTCBB: PLYPF)(BERLIN: A0LGDN)(FRANKFURT: POZ) is pleased to announce the appointment of Mr.

Philip C.

Kempisty to the Board of Directors.

Kempisty is a Certified...

Genetic Engineering News:  Jan 20 2010 10:28PM
Matching: poly
Find similar documents
HTML
58%
Poly-Pacific Announces Appointment of Philip Kempisty to Board of Directors and Proposed Share Consolidation
Poly-Pacific International Inc.

("Poly-Pacific" or the "Company") (TSX VENTURE:PMB)(OTCBB:PLYPF)(BERLIN:A0LGDN)(FRANKFURT:POZ) is pleased to announce the appointment of Mr.

Philip C.

Kempisty to the Board of Directors.

Kempisty is a...

Individual.com:  Jan 20 2010 10:38PM
Matching: poly
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.